Understand the host genetics of COVID-19
Lead the COVID-19 research effort
The rapid generation of new data and diverse lines of inquiry can complicate which genes to focus on when researching COVID-19 host response.
The COVID-19 module within the Congenica Clinical Decision Support platform focuses on the genetic underpinnings of COVID-19 infection using curated gene panels relevant for SARS-CoV-2 infection and the latest findings from the growing scientific literature, enabling you to identify the causes, progression, treatment and prevention of COVID-19.
Fast-track your research
Powering analysis with Congenica COVID-19 accelerates research of individual genomic variation and virus susceptibility, severity, and clinical outcomes. The module automatically directs you to variants in relevant genes and facilitates flexible analysis of additional genes through gene searches, expert curated custom gene panels, and existing gene panels such as the PanelApp COVID-19 Research Panel, to include a broader set of potentially related genes for research.
Perform evidence-based analysis
Congenica COVID-19 highlights literature providing data from the latest research including the EMBI COVID-19 data portal, GENCODE and coronavirus literature searches, supporting you with up-to-date evidence of gene association with coronaviruses including SARS-CoV-2 and variants potentially associated with COVID-19 susceptibility or severity.
Determine susceptibility and host response
The software enables you to prioritize variants in curated genes using COVID-19-related Human Phenotype Ontology (HPO) terms such as loss of smell or dry cough and to include information about viral strain or treatment regimen. You can also identify other individuals with the same variant, identify patterns in HPO terms and build knowledgebases for understanding the biology of COVID-19 susceptibility and host response.
Produce expert COVID-19 research reports
Report on variants using custom COVID-19 report templates to show evidence for reported genes in association with COVID-19 host response and SARS-CoV-2 susceptibility. Congenica COVID-19 reports include COVID-relevant meta data such as viral strain and SARS-CoV-2 antigen/antibody status and are instantly generated within the software to consistently present new findings as you discover them.
Analyze and interpret host genetics of COVID-19 rapidly, reliably and with complete confidence